Wei et al. observed significant tumor regression and decreased PSMA expression in cerebral lesions based on 68Ga-PSMA PET/CT imaging performed after 177Lu-PSMA-617 treatments combined with radiotherapy in two prostate cancer patients with cerebral metastasis [25]. The gene discussed is FOLH1; the disease is prostate carcinoma.